Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection
Public ClinicalTrials.gov record NCT02378935. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Global, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of GS-9857 Plus Sofosbuvir/GS-5816 Fixed Dose Combination in Subjects With Chronic Genotype 1 HCV Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This primary objectives of the study are to evaluate the safety, tolerability, and efficacy of voxilaprevir (VOX) plus sofosbuvir/velpatasvir (SOF/VEL) fixed dose combination (FDC) ± ribavirin (RBV) in adults with chronic genotype 1 hepatitis C virus (HCV) infection.
Study identification
- NCT ID
- NCT02378935
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 17, 2015 (Actual)
- Primary completion
- Feb 1, 2016 (Actual)
- Completion
- Apr 12, 2016 (Actual)
- Last update posted
- Mar 6, 2020
2015 – 2016
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | — | — |
| Stanford University | Palo Alto | California | — | — |
| Huntington Memorial Hospital Liver Center | Pasadena | California | — | — |
| Medical Associates Research Group, Inc. | San Diego | California | — | — |
| University of Colorado | Denver | Colorado | — | — |
| Borland-Groover Clinic | Jacksonville | Florida | — | — |
| University of Miami | Miami | Florida | — | — |
| Orlando Immunology center | Orlando | Florida | — | — |
| South Florida Center of Gastroenterology, P.A. | Wellington | Florida | — | — |
| Center for Hep C/Atlanta Medical Center | Atlanta | Georgia | — | — |
| Gastrointestinal Specialists of Georgia, PC | Marietta | Georgia | — | — |
| University of Chicago | Chicago | Illinois | — | — |
| Indiana University | Indianapolis | Indiana | — | — |
| Indianapolis Gastroenterology & Hepatology, Inc. | Indianapolis | Indiana | — | — |
| Beth Isreal Deconess Medical Center | Boston | Massachusetts | — | — |
| Massachusetts General Hospital | Boston | Massachusetts | — | — |
| Henry Ford Hospital and Health System | Detroit | Michigan | — | — |
| ID Care | Hillsborough | New Jersey | — | — |
| Southwest Care Center | Santa Fe | New Mexico | — | — |
| North Shore/Long Island Jewish PRIME | Manhasset | New York | — | — |
| Mount Sinai Beth Israel | New York | New York | — | — |
| Cumberland Research Associates, LLC | Fayetteville | North Carolina | — | — |
| Digestive Health Specialists, PA | Winston-Salem | North Carolina | — | — |
| University of Pennsylvania Health Systems | Philadelphia | Pennsylvania | — | — |
| UPMC Center for Liver Diseases | Pittsburgh | Pennsylvania | — | — |
| Medical University of South Carolina | Charleston | South Carolina | — | — |
| Gastro One | Germantown | Tennessee | — | — |
| Nashville Gastrointestinal Specialists, Inc. | Nashville | Tennessee | — | — |
| Texas Liver Institute | San Antonio | Texas | — | — |
| Liver Institute of Virginia | Richmond | Virginia | — | — |
| Swedish Medical Center | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02378935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02378935 live on ClinicalTrials.gov.